Skip to main content
. 2017 Nov 20;25(2):123–130. doi: 10.1530/ERC-17-0396

Figure 4.

Figure 4

Change in EP score before and after treatment with neoadjuvant letrozole in combination with palbociclib. Each line represents the data for individual patient. EP score <5 was classified as low risk for distance recurrence; EP score ≥5 was stratified as high risk. EP, EndoPredict.